Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples

PROVIDER: PRJNA218119 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR969851_1.fastq.gz	Fastqsanger.gz
	SRR969851_2.fastq.gz	Fastqsanger.gz
	SRR969852_1.fastq.gz	Fastqsanger.gz
	SRR969852_2.fastq.gz	Fastqsanger.gz
	SRR969853_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

E-GEOD-54678

Project description:A pivotal role of SRC-2 in Metastatic and Castration Resistant Prostate Cancer

2015-08-04 | E-GEOD-54678 | ExpressionAtlas

E-GEOD-3325

Project description:Transcription profiling by array of human benign prostate, primary and metastatic prostate cancer samples to reveal signatures of metastatic progression

2025-01-24 | E-GEOD-3325 | ExpressionAtlas

E-GEOD-58966

Project description:Transcription profiling by high throughput sequencing in castration resistant prostate cancer cell lines

2025-01-24 | E-GEOD-58966 | ExpressionAtlas

Homo sapiens

Project description:Whole Genome Methylation Analysis of Metastatic Castration Resistant Prostate Cancer

| PRJNA149609 | ENA

Epigenetic Activation and alteration of chromatin structure regulated by NSD2 in metastatic castration-resistant prostate cancer (Hi-C)

Project description:To elucidate the regulation of NSD2 in metastatic castration-resistant prostate cancer(CRPC), we performed Hi-C against castration-sensitive prostate cancer cell line LNCaP and metastatic castration-resistant prostate cancer cell lines, PC3 respectively. In metastatic CRPC, we found specific regions of activation with epigenetic changes.

2024-09-04 | GSE248627 | GEO

Epigenetic Activation and alteration of chromatin structure regulated by NSD2 in metastatic castration-resistant prostate cancer (ChIP-seq)

Project description:To elucidate the regulation of NSD2 in metastatic castration-resistant prostate cancer(CRPC), we performed ChIP-seq of H3K36me2, H3K27me3, H3K4me1, H3K4me3,H3K27ac and NSD2 against castration-sensitive prostate cancer cell line LNCaP and metastatic castration-resistant prostate cancer cell lines, PC3 and DU145, respectively. In metastatic CRPC, we found specific regions of activation with epigenetic changes.

2024-09-04 | GSE248629 | GEO

Epigenetic Activation and alteration of chromatin structure regulated by NSD2 in metastatic castration-resistant prostate cancer (RNA-seq)

2024-09-04 | GSE248628 | GEO

Homo sapiens

Project description:Expression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer

| PRJNA147325 | ENA

Homo sapiens

Project description:Castration-Resistant Prostate Cancer (CRPC)

| PRJNA149075 | ENA

E-MTAB-5102

Project description:Development of a small molecule for treatment of castration resistant prostate cancer via androgen receptor and IL6/STAT3 pathways

2025-01-23 | E-MTAB-5102 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data